Missed opportunities for physical activity management at key points throughout the chemotherapy pathway for colorectal survivors: an observational interview study by Veal, I et al.
1  
 
Missed opportunities for physical activity management at key points throughout the  
chemotherapy pathway for colorectal survivors: An observational interview study. 
I. Veal 1, 2, N. Peat 1, G.D. Jones 1, V. Tsianakas 2, J. Armes 3 
1 Guy’s and St Thomas’ NHS Foundation Physiotherapy Department, Great Maze 
Pond, London, SE1 9RT 2 King’s College London, Florence Nightingale Faculty of 
Nursing & Midwifery, James Clerk Maxwell Building, 57 Waterloo Road, London SE1 
8WA. 3 University of Surrey, School of Health Sciences, Guildford, Surrey, GU2 7XH 
 
 
Corresponding Author: Vicki Tsianakas, Florence Nightingale Faculty of Nursing & 
Midwifery, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, 
London SE1 8WA, Tel: 020 7848 3085, email: Vicki.Tsianakas@kcl.ac.uk 
Funding: This study was undertaken as part of a Masters in Clinical Research 
programme and funded by National Institute of Health Research (NIHR) through the 
ICA HEE/NIHR Integrated Clinical Academic Programme. 
 
ORCID  
Isla Veal  0000-0002-5470-0550 
Jo Armes  0000-0002-7994-0796 
Gareth D Jones 0000-0001-5516-9418 
Vicki Tsianakas 0000-0003-4177-6019 
Nicola Peat  0000-0001-6360-9030 
 
Compliance with Ethical Standards 
2  
All procedures performed in studies involving human participants were in accordance 
with the ethical standards of the institutional and/or national research committee 
Research Ethics Committee (15/EE/04/34) and with the 1964 Helsinki declaration 
and its later amendments or comparable ethical standards [1]. Informed consent was 
obtained from all individual participants included in the study. 
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ABSTRACT  
Purpose 
Physical activity (PA) is central to self-management for people with colorectal cancer 
(CRC) to support health behaviour and function secondary to cancer treatment. 
However, there is limited evidence on how health professionals (HPs) promote PA 
during cancer treatment. This study aimed to investigate how and when PA is 
promoted throughout the chemotherapy pathway among colorectal cancer survivors. 
Methods 
A qualitative study was conducted with adults with CRC receiving chemotherapy at a 
large cancer centre.  Cross sectional, observation of clinical consultations was 
conducted at four points during the chemotherapy pathway: prior, midpoint, final 
cycle and 8 weeks following chemotherapy. Following completion of treatment, audio 
recorded, semi-structured interviews were conducted with patients and HPs and 
transcribed verbatim. Codes and themes were identified and triangulated from all the 
data using Framework Analysis. Observational themes are reported and 
complimented by interview data.  
Results 
Throughout the chemotherapy pathway (pre, midpoint, end) many opportunities were 
missed by HPs to promote PA as a beneficial means to maintain functioning and 
ameliorate cancer treatment side-effects. When discussed, PA levels were used only 
to determine fitness for future oncological treatment. No PA promotion was observed 
despite patients reporting low PA levels or treatment side-effects. Post-treatment, PA 
promotion was more routinely delivered by HPs, as evidenced by problem-solving 
and onward referrals to relevant HPs.  
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Conclusion 
PA promotion was largely absent during treatment despite it being a key component 
of patient self-management following treatment. This suggests considerable missed 
opportunities for HPs to provide cancer survivors with PA evidence-based 
interventions. Further research is necessary to identify how best to ensure PA is 
promoted throughout the cancer journey.  
Implication for cancer survivors 
These findings suggest many may not be receiving support to be physically active 
during treatment. 
Keywords 
Self-management; colorectal neoplasms; qualitative; physical activity 
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INTRODUCTION  
By 2030, global cancer incidence will reach 26 million [2] with colorectal cancer 
(CRC) third among most common tumour-sites [3]. In 54% of cases,  cancer 
treatment side-effects include peripheral neuropathies, deconditioning, weight gain, 
and reduced functioning [4] with limitations in physical performance burdening 
survivors twice as much as those living without cancer [5]. There is no doubt 
therefore that management of the disease, and the effects of cancer treatment, will 
collectively impact healthcare resource allocation. 
Evidence of health benefits from physical activity (PA) for people with cancer are 
compelling [5, 6] including reduced recurrence and mortality [6], improved 
functioning [7] and alleviating treatment-related side-effects such as pain, fatigue and 
anxiety [8–10]. The promotion of PA by health professionals (HPs) following cancer 
diagnosis is a ‘teachable moment’ to realise health outcomes and reduce healthcare 
costs [11–14]. While there is some evidence HPs promote PA in oncology [15, 16], 
recommendation rates at any stage of the cancer pathway reach only 29% by pan-
disciplinary HPs [17] and 30% by oncology physicians [47] with PA training deficits 
cited as a barrier in both studies. Even when offered, the majority of PA advice by 
HPs does not align with current recommendations [17]. Thus, with professional PA 
advice imperfect, only 20% of people with CRC meeting exercise recommendations 
[18], and patients reporting a lack of guidance on being physically active [19] it is 
likely the advice delivered is not having its desired impact. However, data these 
conclusions are based on are self-report which can be prone to social desirability 
bias [15]. Therefore, it is of utmost importance to assess how successfully HPs are 
promoting PA by a method of enquiry that enables a fuller picture of behaviour. 
Consequently, the aim of this study was to use observational methodology to 
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determine whether, and how, HPs promote PA for people undergoing treatment for 
CRC. 
 
METHODS  
A non-participant observational study was conducted with a purposive sample of 
adults with CRC undergoing chemotherapy at a large cancer centre in London, 
United Kingdom. Observational data were collected in order to assess what PA 
support was delivered, in contrast to what was reported to be delivered. Interviews 
with patients and HPs were conducted to supplement observational data in 
highlighting similarities and differences between reported behaviour and 
observational data. HP-patient consultations were observed by the researcher (IV) 
and PA content was captured using a template and concurrent field notes. The 
template was developed through preliminary observations of consultations and in 
discussion with patients and HPs. PA was defined as any activity that requires 
energy expenditure through movement for example swimming or walking [20]. In 
order that commonalities and discrepancies between observed information conveyed 
by the HP and its perception by the patient could be ascertained, interviews with HPs 
and patients were conducted at the final assessment.  
Cross-sectional, observational data were collected at each of the following four 
points: 1) before chemotherapy, 2) during chemotherapy, 3) midpoint of 
chemotherapy, and 4) 8 weeks following treatment completion. Observations 
consisted of consultations between HP and patients or interactions between HP, 
patients, and companions during intravenous chemotherapy. While the same 
patients were not observed at each time point due to resource limitations, this 
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maximised the number of patients involved in the data collection. It was not possible 
to collect demographic data of those observed due to pragmatic and ethical reasons. 
Concurrent field notes were used to describe the environment, people involved, 
activities and actions, timing and sequencing of events, goals and emotions 
expressed.  
Patients who were non English speakers, had previous CRC or for whom PA was 
contraindicated (e.g. cardiac instability) were excluded. HPs observed included 
oncology consultants, registrars, specialist CRC nurses and chemotherapy nurses.  
Eligible patients were identified by their HP and provided with written information. 
Verbal and written consent was obtained for observation of chemotherapy delivery 
and consultations respectively.  To avoid a change in behaviour, participants were 
informed that we were observing the discussions on the topic ‘what you can do to 
help yourself’. Patients from the final consultation point of end of treatment were 
invited to participate in semi-structured interviews. These were conducted with 
consenting patients to gain an understanding of perceptions and interpretations of 
PA advice received or delivered. 
Interviews were conducted following completion of all the observations in order to 
avoid future participants becoming aware of the study’s intent. Interviewees selected 
either face-to-face or telephone modalities according to personal preference and 
interviews were conducted using a topic guide which was developed and trialled with 
patients prior to usage. PA was discussed in relation to its definition, promotion, 
barriers during treatment and challenges by both HP and patients. Additionally, 
challenges faced by HPs in promoting PA as a self-management technique was 
included. Written informed consent was obtained for all interviews. Interviews were 
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audio recorded, transcribed verbatim, and anonymised. The number of 
observations/interviews was sufficient to achieve data saturation [21] 
To enhance credibility and transparency of the findings by highlighting potential 
areas of influence, the researcher (IV) kept a reflexive account after each 
observation or interview in which she explored how her prior knowledge, attitudes 
and perception influenced the data analysis. The researcher was a female clinician 
with over 10 years’ experience as a physiotherapist who viewed PA participation as 
important for people with cancer to maintain their wellbeing and promote recovery. 
Nevertheless, she had prior insight that HPs’ inconsistently promote PA.  
During the analysis codes and themes were identified in the observational and 
interview data using Framework Analysis (FA) [22]. FA is popular in healthcare 
research [23]  as it permits concurrent analysis of observational and interview data 
[24]. A selection of interview transcripts were also coded by two experienced 
researchers (JA, VT) to enhance reliability and rigour [25]. Subsequently, 
observational and interview data were triangulated to highlight commonalities and 
discrepancies between observed PA advice delivery, and subjects’ and HP’s 
perception of delivery. The observations (at each time point) and the interview data 
were separately coded into themes. The interview themes that pertained to each 
observational time point were compared and contrasted with the observational data 
for commonalities and discrepancies. Observational themes (drawn from the 
analysis of field notes) at each time point are reported and complemented by 
illustrative quotes from the interview data. Contradictory results are discussed in 
detail in order to explore why discrepancies might exist. 
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The themes are reported using quotations from interview.  Observation data are 
reported using the following codes: PC= Pre chemotherapy, CD= Chemotherapy 
delivery, MPC= Mid-point chemotherapy, EOT= End of treatment Consultation.  
The study was granted ethical approval by the Research Ethics Committee 
(15/EE/04/34) and conducted in accordance with the ethical standards of the 
institution, and the 1964 Helsinki declaration [1]. 
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RESULTS 
Patient consent was provided to collect the following cross-sectional observational 
data PC (n=10), CD (n=6 sessions), MPC (n=10), mid treatment (n=10), and EOT 
(n=10) as described in Table 1.   
Table 1: Detailed description of observations 
Setting  Point in treatment pathway 
Number of Observations 
Duration per observation (minutes) 
Pre-chemotherapy consultations (PC): HP led consultation prior to first chemotherapy cycle 
Following surgery and prior to chemotherapy  
 10  60 
Chemotherapy on Day Unit (CD): Delivery of chemotherapy Chemotherapy delivery with multiple patients 6 sessions 120 minutes per session 
Chemotherapy consultation Mid-Point chemotherapy (MPC): HP led consultation prior to next chemotherapy prescription 
Following 8-12 chemotherapy cycles  10 10-30 
End of treatment consultation (EOT): Conducted by HP following completion of treatment 
8 weeks post chemotherapy 10 60 
 
Following completion of all the observations, 16 interviews were undertaken with 8 
CRC patients (Table 2) and 8 HPs (Table 3) lasting a maximum of 60 minutes (range 
=30-60).  
Table 2: Interviewee characteristics: Patients  
Number Age Gender Diagnosis Employment Sequence of Treatment 
1 56 Male 2013 Full time Surgery (no stoma), radiotherapy, chemotherapy 
2 66 Male 2015 Part-time Surgery (no stoma) chemotherapy 
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Table 3: Interviewee Characteristics: Health Professionals  
Number Profession Oncology experience (years) Gender 
1 Chemotherapy nurse 3 Female 
2 Colorectal senior nurse 10 Female 
3 Colorectal senior nurse 2 Female 
4 Colorectal senior nurse 2 Female 
5 Consultant 5 Male 
6 Consultant 20 Male 
7 Chemotherapy senior nurse 20 Female 
8 Chemotherapy nurse 9 Female 
 
A number of themes emerged during analysis of the observational data augmented 
with interview data as follows:  
PA is not routinely promoted prior to chemotherapy 
Prior to chemotherapy, patient/HP consultations lasted between 45 and 60 minutes. 
The consultation was HP-led and delivered structured information including 
treatment delivery, side effects, and diet advice. Questions were encouraged 
throughout, however, patients appeared overwhelmed by the amount of information. 
3 51 Male 2015 Illness leave Surgery (no stoma) chemotherapy 
4 55 Male 2014 Full time Surgery (no stoma) chemotherapy 
5 67 Female 2013 Retired Chemotherapy/radiotherapy, surgery (with stoma), chemotherapy 
6 57 Male 2015 Illness leave Surgery (no stoma), chemotherapy 
7 69 Male 2015 Retired Surgery (no stoma), chemotherapy 
8 72 Female 2015 Retired 
Brain radiotherapy, surgery to brain, 
surgery to colorectal (with stoma), 
chemotherapy 
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PA was not discussed routinely in the consultations prior to chemotherapy. HPs 
rarely raised the topic and it was only discussed in three of ten observations when 
patients asked about PA. Interview data also supports this finding.  
“To be honest, I don't bring it up much unless they ask, I don't think I 
had thought about it to be honest” (#1 HP of PC consultation). 
HPs highlighted in the interviews that training in the delivery of PA advice and 
support to change behaviour had not been part of their training. 
“We aren’t trained to communicate in that way…  it’s a different way 
of talking with somebody, rather than saying these are all the side-
effects you can get, just tell us and we’ll manage it. It’s a completely 
different skill so there is different training [needed].” (#7 HP 
Interview)   
Patients sought reassurance regarding safe types of PA during chemotherapy and 
were advised that: 
“Exercise is good for managing fatigue” (#6 Reported speech of a 
HP prior to chemotherapy) 
Recommendations on the volume, intensity and duration of PA were not observed, 
except for advice to be conservative in their activities.  
“I normally recommend to listen to their body, see how they feel 
during the chemotherapy. If they feel they can carry on with their 
activities, that’s absolutely fine. But normally we recommend some 
gentler exercise to see how they get on”. (# 1 HP interview) 
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The interview findings showed patients perceived they were offered limited 
information about PA during treatment by HPs throughout their journey.  
“Yeah, I think they did [mention PA], but it was just, you know, pretty 
basic, just get out and about and you know. I don’t think it was really 
emphasised that much” (#2 Patient Interview) 
This lack of PA advice provision by HPs during consultations represents a missed 
opportunity to promote the role of PA in managing treatment side-effects and 
maintenance of fitness during chemotherapy. Moreover, whilst not observed, 
patients reported PA advice was given prior to treatment about avoiding swimming 
and heavy lifting activities, as this may cause peripherally inserted central catheters 
(PICC line) to dislodge or block. For one patient however, this message led them to 
avoid all PA during treatment. 
“For six months I was happy not to do any physical exercise … [that 
could potentially] pull out my PICC line or interfere with the chemo in 
any way… I would have loved to have done it, but I just didn’t want 
to test that PICC line” (#7 Patient interview) 
Rather than find alternative PAs which were safe to undertake with a PICC line, this 
patient chose not to do any PA, demonstrating a further missed opportunity. 
PA promotion absent during delivery of chemotherapy 
Advisory PA discussion was not observed during chemotherapy delivery other than 
on two occasions when HPs were observed advising patients to “maintain your 
mobility” or as a means to help unblock a peripheral line. Advice was not given on 
the type, volume or intensity of PA.   
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 “Patients around me are being recommended by their nurses to get 
up, unplug their drip stands and go for a walk. No advice is given as 
to how long or how often or where to go”. (#1 Observation using 
template CD) 
Despite observations confirming HPs and patients interact during prolonged 
treatment times (~4-6 hours), none of the interactions were observed as being 
concerned with PA’s role in managing common side-effects of treatment including 
fatigue, reduced mobility, or physical deconditioning. In addition, while the primary 
purpose of the day unit is the safe administration of chemotherapy, it was 
nonetheless interesting, but not surprising, to observe patients choosing to be 
sedentary for majority of time there with only low intensity PA observed.  
Patient-to-patient conversations about PA were observed infrequently. Only one 
discussion was observed where a patient reported using PA as a coping strategy to 
manage treatment side-effects which included low energy. 
“Chloe volunteered, ‘I had a lack of energy, so I exercise, I go 
swimming and go to the gym, I just get on with life’… you have to 
control it, you have to have a positive thinking or it will control you’. It 
seems that Chloe has used exercise as a coping strategy, for her 
energy and for her sense of command over the situation”. (#5 
Observation CD) 
 
Physical activity levels – an indicator of fitness for further chemotherapy  
Observation of consultations between HPs (predominately doctors) and patients at 
the MPC followed a set structure which assessed the cancer treatment and the 
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resulting side effects. The HP used activity levels commonly assessed using the 
Eastern Cooperative Oncology Group performance scale [26] to determine fitness for 
the next chemotherapy treatment. Low activity/high sedentary behaviour is 
analogous to poor health and can risk the next chemotherapy cycle intervention 
resulting in treatment delays, reduced dosage or premature chemotherapy 
completion, and potentially poorer cancer outcomes.   
“So … you're generally spending 50% of the day resting, I'm asking 
to know if I have to reduce the dose” (#4 Observation MPC) 
This quote is from an example where a patient was sedentary for the majority of the 
day due to fatigue and deconditioning. The consequence was his treatment was 
delayed in order to allow for recovery, yet no advice was offered to facilitate their 
recovery.  
Treatment side-effect discussions initiated by HPs at the MPC were task-focussed 
and formulaic in topic discussion and observed to include fatigue, deconditioning and 
nausea, all of which could negatively impact PA behaviour during treatment. Of the 
ten consultations observed, in only one did a HP offered advice on PA as a way to 
minimise treatment side-effects.  
PA promotion is more prominent following completion of cancer treatment 
At EOT, there was marked a change in the manner, style and content of HP-led 
consultations (mainly nurses). The specialist colorectal cancer HP equally lead the 
consultation suggesting a changed HP-patient relationship. Furthermore, PA was 
regularly discussed in the EOT consultation by the HP and the patient in the context 
of recovering from cancer treatment. Barriers to PA, including residual treatment 
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side-effects, were discussed and in many cases observation revealed HP and 
patients jointly identified ways to address them. 
“‘I can’t run because of my feet; I feel cold, it’s so cold’. The HP 
helped him to problem solve by reminding him of other activities 
which would also help with weight management including cycling, 
swimming to ‘help him keep mobile and manage his weight’”.  (#4 
Observation using a template at the EOT) 
HPs were also observed referring patients to relevant colleagues, including oncology 
physiotherapists, to offer further specialist support. The primary reason for referral to 
physiotherapy was a mutual acknowledgement that the person lacked confidence in 
returning to or increasing PA.  
“The nurse suggested referring him to the local oncology 
physiotherapists for an assessment as it ‘would give him the 
confidence again’” (#5 Observation EOT) 
Interviewed patients described the need to increase PA participation, including 
reducing cancer recurrence and weight management as part of a healthy lifestyle.  
“Dominic’s second goal is to reduce the risk of recurrence through 
eating healthily as weight gain and a poor diet can cause CRC. Yet, 
he mused, I had a good diet before so now it will have to be even 
better.” (#4 summary of patient interview as recording failed)  
While PA type was often discussed, once again the consultations did not include 
specifics on frequency, volume and intensity.  
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DISCUSSION  
HPs have been shown to be influential during the ‘teachable moment’ following a 
cancer diagnosis in supporting health behaviour change [27–29]. Furthermore, 
following a cancer diagnosis, people want more information concerning cancer 
treatment side-effects and strategies on management [30]. However, this study 
questions how successfully the opportunity is used in CRC.  
Unlike others, our novel study focussed on the observable, rather than self-reported, 
practices of HPs in promoting PA during treatment and explored the relationship with 
patient perceptions of the information. The results demonstrated a general lack of PA 
promotion throughout the chemotherapy pathway with missed opportunities at all 
stages during treatment, in keeping with previous self-reported findings where HPs 
promoted PA in only 6-44% of cancer patient consultations [31, 32]. This is mirrored 
by the lack of patient recall of PA promotion during treatment in this study and others 
where only a third recalled advice [33]. Consequently, rather than utilising the cancer 
diagnosis as an opportunity to increase PA participation, this and other studies have 
shown this does not occur and may result in reduced participation [34]. 
It is clear from the results that PA is not being recommended as part of cancer care. 
Our data suggests a lack of HP confidence on PA advice. Our observational data 
confirmed that during MPC discourse about fitness for forthcoming chemotherapy 
cycles was prioritised, with very little opportunity to discuss other issues. The MPC 
were predominately led by the HP, and followed a predictable pattern of question 
and response meaning there was little deviation from the set pattern. Therefore, it 
was not obvious to the patient that the HP would enquire beyond their side effects 
and treatment planning, for instance PA. In contrast, PA was regularly discussed in 
the post treatment consultations which have been designed specifically to address a 
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wide range of patient concerns as part of the Recovery Package [35] including diet 
and exercise. This may explain the focus of the HPs on PA support and highlights 
the importance of context in patient and HP at this point. While it is promising that PA 
levels were discussed as part of the performance status assessment prior to and 
during treatment, the aim was to verify fitness for further chemotherapy, not as a 
teachable moment to use PA to minimise treatment side-effects. This missed 
opportunity may have occurred due to the treatment-orientated approach with HPs 
receiving little support to adopt a more holistic perspective of PA in the management 
of iatrogenic side-effects. Other studies support this interpretation, for example 
patient’s symptoms were acknowledged but dismissed as expected chemotherapy 
side-effects [36, 37]. An alternative approach could be to consider treatment 
consultations as an opportunity for HPs to discuss treatment side-effects 
management with PA and thereby improve chemotherapy tolerance and treatment 
outcomes [33].  
PA can play a significant role in maximising health benefits and promoting well-being 
as part of a self-management programme commonly used in long-term conditions  
alongside HP support [38, 39]. Two tools used to enhance PA levels in other long-
term conditions could be deployed within the milieu of cancer-treatment culture. 
These include Brief Advice [40, 41], and self-management programmes [42]. Brief 
Advice for PA is a short verbal intervention addressing a patient’s information needs, 
motivation and goal setting [13], while self-management programmes are more 
comprehensive combining education, exercise and problem solving [42]. Both 
approaches have been demonstrated to increase PA participation and improve 
health outcomes for people with cancer [13, 43].  
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It is noted, however, that investment in HP training would be required to use these 
methods as previous authors have reported the lack of PA promotion by HP is 
caused by inexperience [44], lack of confidence [16, 45], or a need for training [46].  
HPs teaching PA as a self-management skill is not widespread practice with HPs 
often inexperienced in teaching these skills [44], findings also supported in our 
interview data.   
There are substantial challenges, therefore, in implementing both these HP-led 
approaches which will need to be factored into future efficacy studies. PA remains an 
area where patients can take the lead in their care with support and encouragement 
from HPs when suitable and person-centric information is delivered. 
  
20  
LIMITATIONS  
This study used observation and interview methods successfully in investigating how 
PA is discussed during treatment. However, this approach was not without 
limitations. While key time points were identified for observation of clinical practice, 
the data were cross-sectional and not longitudinal. Therefore, the results are not 
comprehensive of the whole CRC pathway, as highlighted by interviewees reporting 
that PA advice was delivered in non-observed settings. While our sample was 
sizable we must acknowledge it was nevertheless one of convenience and subject to 
selection bias. Applicability of our results should therefore take this into account and 
be limited to patients with CRC undergoing curative chemotherapy treatment in an 
established cancer centre. In addition, the amount of observational data available for 
analysis is predicated on the timescale of the phenomenon under observation. We 
observed interactions between clinicians and patients which were relatively short in 
duration [approx. 20 minutes]. We acknowledge therefore that our methods limited 
the depth of analysis we were able to undertake. 
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RECOMMENDATIONS 
This was a small scale qualitative study, therefore generalisations should be scaled 
accordingly. However, confidence in the data is derived from the congruence 
between our findings and those of other studies.  Our findings identify the 
inconsistent message being delivered to patients currently. The onus is on HPs, 
therefore, to examine their practice in promoting PA. Further research is needed to 
conduct implementation studies to improve PA promotion practice and assess the 
impact on PA participation.  
  
22  
CONCLUSIONS 
Findings from our study show that PA was inconsistently promoted to people with 
CRC during treatment. Missed opportunities occurred including the assessment of 
PA levels to determine fitness for further chemotherapy which did not result in HP 
promotion of PA. On completion of treatment, PA discussion in consultations was 
more prominent. However, any reference to types of PA or dose remained lacking.  
Further investigation is needed to enhance patient’s ability to take a greater role in 
their care via HP promotion of PA during treatment.  PA has the potential to be used 
by patients as a strategy to manage treatment side-effects and maintain fitness 
throughout treatment, however, our findings suggest it is not fully recognised. 
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